# Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)

> **NCT01539343** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 31 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** Antimicrobial Solution

## Key facts

- **NCT ID:** NCT01539343
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2016-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539343, "Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01539343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*